(+)-Catechin, an ingredient of green tea, protects murine microglia from oxidative stress-induced DNA damage and cell cycle arrest

Journal of Pharmacological Sciences

Volumn 98, Issue 1, 2005, Pages 16-24

  Huang, Qing ^a   Wu, Li Jun ^a   Tashiro, Shin Ichi ^b   Gao, Hui Yuan ^a   Onodera, Satoshi ^b   Ikejima, Takashi ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

(+) catechin; Cell cycle arrest; DNA damage; NF B; P53

Indexed keywords

ACETYLCYSTEINE; CATECHIN; HYDROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P53; TERT BUTYL HYDROPEROXIDE;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE ARREST; CELL DEATH; CELL LEVEL; CELL LINE; CELL NUCLEUS; CELL PROTECTION; CELL SURVIVAL; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; MICROGLIA; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN TRANSPORT; TEA; UPREGULATION;

EID: 20444387289     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.FPJ04053X     Document Type: Article

References (38)

1. Markesbery WR. Oxidative stress hypothesis in Alzheimer's disease. Free Radical Biol Med. 1997;23:134-147.
2. Fahn S, Cohen G. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann Neurol. 1992;32:804-812.
3. Bergeron C. Oxidative stress: its role in the pathogenesis of amyotrophic lateral sclerosis. J Neuro Sci. 1995;129:81-84.
4. Kannan K, Jain SK. Oxidative stress and apoptosis. Pathophysiology. 2000;7:153-163.
5. Boyer J, Liu RH. Apple phytochemicals and health benefits. J Nutr. 2004;12:3-5.
6. Valdez LB, Alvarez S, Zaobornyj T, Boveris A. Polyphenols and red wine as antioxidants against peroxynitrite and other oxidants. Biol Res. 2004;37:279-286.
7. Xu LX, Liu AR. Determination of active principles in Chinese herbal drugs. III. Determination of catechin in Acacia catechu (L) Willd. Yao Xue Xue Bao. 1980;15:636-640.
8. Pomponio R, Gotti R, Santagati NA, Cavrini V. Analysis of catechins in extracts of cistus species by microemulsion electrokinetic chromatography. Chromatogr A. 2003;990:215-223.
9. Manning J, Roberts JC. Analysis of catechin content of commercial green tea products. J Herb Pharmcother. 2003;3:19-32.
10. Stich HF. Teas and tea polyphenols as inhibitors of carcinogen formation in model systems and man. Prev Med. 1992;21:377-384.
11. Lin JK, Liang YC, Lin-Shiau SY. Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade. Biochem Pharm. 1999;58:911-915.
12. Suzuki H, Yamamoto S, Hirayama C, Takino T, Fujisawa K, Oda T. Cianidanol therapy for HBs-antigen-positive chronic hepatitis: a muticentre, double-blind study. Liver. 1986;6:35-44.
13. Jeon SE, Choi-Kwon S, Park KA, Lee HJ, Park MS, Lee JH, et al. Dietary supplementation of (+)-catechin protects against UVB-induced skin damage by modulating antioxidant enzyme activities. Photo dermatology, photo immunology, and photo medicine. 2003;19:235-241.
14. Wcyant MJ, Carothers AM, Danncnberg AJ, Bertagnolli MM. (+)-Catechin inhibits intestinal tumor formation and suppresses focal adhesion kinase activation in the min/+ mouse. Cancer Res. 2001;61:118-125.
15. Lee KM, Kang BS, Lee HL, Son SJ, Hwang SH, Kim DS, et al. Spinal NF-κB activation induces COX-2 upregulation and contributes to inflammatory pain hypersensitivity. Eur J Neurosci. 2004;19:3375-3381.
16. Vicent B, Mohamed BA, Anne-Cécile H, Patrick V, Pierre R, Sylvie D, et al. Nuclear factor-κB, cancer, and apoptosis. Biochem Pharm. 2000;60:1085-1090.
17. 2 arrest after DNA damage. Science. 1998;282:1497-1501.
18. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, et al. Single cell gle/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen. 2000;35:206-221.
19. Nalini K, Rayudu G, Usha G, Jinah C, Henry JF. Role of protein kinase C in basal and hydrogen peroxide-stimulated NF-κB activation in the murine macrophage J774A.1 Cell line. Arch Biochem Biophys. 1998;350:79-86.
20. Zhao K, Zhao GM, Wu D, Soong Y, Birk AV, Schiller PW, et al. Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibits mitochondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem. 2004;33:34682-34690.
21. Lazze MC, Pizzala R, Savio M, Stivala LA, Prosperi E, Bianchi L. Anthocyanins protect against DNA damage induced by tertbutyl-hydroperoxide in rat smooth muscle and hepatoma cells. Mutat Res. 2003;535:103-115.
22. 2+ influx in the tert-butyl hydroperoxide-induced apoptosis of HepG2 human hepatoblastoma cells. Exp Mol Med. 1998;30: 137-144.
23. Barzilai A, Yamamoto K. DNA damage responses to oxidative stress. DNA Repair. 2004;3:1109-1115.
24. Zhao HB, Lin SQ, Liu JH, Lin ZB. Polysaccharide extract isolated from Ganoderma lucidum protects rat cerbral cortical neurons from hypoxia/reoxygenation injury. J Pharmacol Sci. 2004;95:294-298.
25. Jeffrey AK, Susan LA. Oxidative stress, cell cycle, and neurodegeneration. J Clin Inv. 2003;111:785-793.
26. Catherine M, Marie-Jeanne R, Pierre H. Redox signaling and transition metals in the control of the p53 pathway. Biochem Pharma. 2000;59:25-33.
27. Conte A, Pellegrini S, Tagliazucchi D. Effect of resveratrol and catechin on PC12 tyrosine kinase activities and their synergistic protection from beta-amyloid toxicity. Drugs Exp Clin Res. 2003;29:243-255.
28. Nobre Junior HV, Cunha GM, Maia FD, Oliveira RA, Moraes MO, Rao VS. Catechin attenuates 6-hydroxydopamine (6-OHDA)-induced cell death in primary cultures of mesencephalic cells. Comp Biochem Physiol C Toxicol Pharmacol. 2003;136: 175-180.
29. Jeremy JY, Shukla N, Muzaffar S, Handley A, Angelini GD. Reactive oxygen species, vascular disease and cardiovascular surgery. Curr Vasc Pharmacol. 2004;2:229-236.
30. Poli G, Leonarduzzi G, Biasi F. Oxidative stress and cell signalling. Curr Med Chem. 2004;11:1163-1182.
31. 2 response of normal human fibroblasts. Biochem J. 2000;347:543-551.
32. 2 in cultured NIH3T3 fibroblasts. Biol Pharm Bull. 2003;26:282-284.
33. Horiguchi Y, Kuroda K, Nakashima J, Murai M, Umezawa K. Antitumor effect of a novel nuclear factor-kappa B activation inhibitor in bladder cancer cells. Expert Rev Anticancer Ther. 2003;3:793-798.
34. Morishita R, Tomita N, Kaneda Y, Ogihara T. Molecular therapy to inhibit NF kappaB activation by transcription factor decoy oligonucleotides. Curr Opin Pharmacol. 2004;4:139-146.
35. Uberti D, Carsana T, Francisconi S, Toninelli GF, Canonico PL, Memo M. A novel mechanism for pergolide-induced neuroprotection: inhibition of NF-kappaB nuclear translocation. Biochem Pharmacol. 2004;67:1743-1750.
36. 2-mediated oxidative stress activates NF-κB in lens epithelial cells. Free Radical Biol Med. 2001;31:651-658.
37. Aleyasin H, Cregan SP, Iyirhiaro GO, Hare MJ, Callaghan SM, Slack RS, et al. Nuclear factor-(kappa)B modulates the p53 response in neurons exposed to DNA damage. J Neurosci. 2004;24:2963-2973.
38. Fukunage K, Kawano T. Akt is a molecular target for signal transduction therapy in brain ischemic insult. J Pharmacol Sci. 2003;92:317-327.